Memokath‑051 (PNN Medical) is a thermo-expandable, nickel-titanium alloy ureteric stent. It is intended as an alternative to conventional ureteric stents for people with malignant or benign ureteric obstruction.
 
Status In progress
Decision Selected
Process MT
ID number 569

Provisional Schedule

Committee meeting: 1 22 July 2022
Draft guidance 15 August 2022 - 13 September 2022
Resolution 27 October 2022
Expected publication 07 December 2022

Email enquiries

Stakeholders

Manufacturers PNN medical A/S
Patient carer organisations Friends of the Cancer Centre (NI)
  Helen Rollason Cancer Charity
  Independent Cancer Patients' Voice
  Macmillan Cancer Support
  Macmillan Cancer Support
  Maggie's Centres
  Maggie's Centres
  Kidney Cancer UK
  Kidney Cancer UK
  Bladder and Bowel Community
  Bladder and Bowel UK
  Bladder Health UK
  ERIC, The Children’s Bowel & Bladder Charity
  International Children's Continence Society (ICCS)
  Urology User Group Coalition
  Urostomy Association (UA)
  GIST Cancer UK
  Pelvic Pain Support Network
  Men's Health Forum (MHF)
  Kidney Cancer Support Network
  National Kidney Federation
  National Kidney Federation
  Go Girls
  Jo's Trust
  Jo's Trust
  Jo's Trust
  The Eve Appeal
  Ovacome
  Ovarian Cancer Action
  Target Ovarian Cancer
  Target Ovarian Cancer
  Target Ovarian Cancer
  The Robin Cancer Trust
Professional groups British Uro-oncology Group (BUG)
  British Association of Day Surgery
  British Association of Urological Surgeons (BAUS)
  British Association of Urological Nurses (BAUN)
  British Association of Paediatric Urology
  British Society of Interventional Radiologists (BSIR)
  Royal College of Physicians
  Royal College of Radiologists
  Royal College of Surgeons
  Royal College of Surgeons ED
  Royal College of Nursing
  Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Boston Scientific
  Department of Health and Social Care
  Devices for Dignity
  Greater Manchester Health & Social Care Partnership
  Health Technology Wales
  Healthcare Improvement Scotland
  HealthTech Alliance
  Johnson & Johnson Medical Ltd
  Medical Technology Group
  Medicines and Healthcare Products Regulatory Agency
  National Wound Care Strategy Programme
  University of Manchester Wounds Research Group
  NHS England
  The British In Vitro Diagnostics Association (BIVDA)
  NHS Digital
  NHS supply chain

Timeline

Key events during the development of the guidance:

Date Update
21 February 2022 Scope published
01 February 2022 Stakeholder registration opens

For further information on our processes and methods, please see our CHTE processes and methods manual